<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2007-10-21" updated="2020-01-02">
  <drugbank-id primary="true">DB05105</drugbank-id>
  <drugbank-id>DB08716</drugbank-id>
  <name>Pleconaril</name>
  <description>Pleconaril is an antiviral drug from _viral capsid inhibitor_ class, manufactured by _Schering-Plough_ and intended for the prevention of acute asthma exacerbations and common cold symptoms in asthmatic patients who have had exposure to _picornavirus_. It acts by inhibiting viral replication. The use of pleconaril has not gained approval by the U.S. Food and Drug Administration (FDA) due to the fact that it has been found to induce CYP3A enzyme activity, therefore increasing the risk for serious drug interactions.</description>
  <cas-number>153168-05-9</cas-number>
  <unii>9H4570Q89D</unii>
  <average-mass>381.349</average-mass>
  <monoisotopic-mass>381.130026072</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>investigational</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A3221</ref-id>
        <pubmed-id>15571999</pubmed-id>
        <citation>Webster AD: Pleconaril--an advance in the treatment of enteroviral infection in immuno-compromised patients. J Clin Virol. 2005 Jan;32(1):1-6.</citation>
      </article>
      <article>
        <ref-id>A3222</ref-id>
        <pubmed-id>12627933</pubmed-id>
        <citation>Florea NR, Maglio D, Nicolau DP: Pleconaril, a novel antipicornaviral agent. Pharmacotherapy. 2003 Mar;23(3):339-48.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Investigated for use/treatment in upper respiratory infection.</indication>
  <pharmacodynamics/>
  <mechanism-of-action>Pleconaril binds to a hydrophobic pocket in viral protein 1, the major protein which makes up the capsid (shell) of picornaviruses. This renders the viral capsid rigid and compressed and prevents the uncoating of its RNA. As a result, the virus is stopped from attaching to the host cell and causing infection.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption>70% (oral)</absorption>
  <half-life/>
  <protein-binding>&amp;gt;99%</protein-binding>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as phenyloxadiazoles. These are polycyclic aromatic compounds containing a benzene ring linked to a 1,2,4-oxadiazole ring through a CC or CN bond.</description>
    <direct-parent>Phenyloxadiazoles</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Azoles</class>
    <subclass>Oxadiazoles</subclass>
    <alternative-parent>Alkyl aryl ethers</alternative-parent>
    <alternative-parent>Alkyl fluorides</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Isoxazoles</alternative-parent>
    <alternative-parent>Organofluorides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <alternative-parent>Phenol ethers</alternative-parent>
    <alternative-parent>Phenoxy compounds</alternative-parent>
    <alternative-parent>m-Xylenes</alternative-parent>
    <substituent>Alkyl aryl ether</substituent>
    <substituent>Alkyl fluoride</substituent>
    <substituent>Alkyl halide</substituent>
    <substituent>Aromatic heteromonocyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Ether</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Isoxazole</substituent>
    <substituent>M-xylene</substituent>
    <substituent>Monocyclic benzene moiety</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organofluoride</substituent>
    <substituent>Organohalogen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Oxacycle</substituent>
    <substituent>Phenol ether</substituent>
    <substituent>Phenoxy compound</substituent>
    <substituent>Phenyl-1,2,4-oxadiazole</substituent>
    <substituent>Xylene</substituent>
  </classification>
  <salts/>
  <synonyms/>
  <products/>
  <international-brands>
    <international-brand>
      <name>Picovir</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antiinfectives for Systemic Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiviral Agents</category>
      <mesh-id>D000998</mesh-id>
    </category>
    <category>
      <category>Antivirals for Systemic Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Common Cold, drug therapy</category>
      <mesh-id/>
    </category>
    <category>
      <category>Direct Acting Antivirals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Oxazoles</category>
      <mesh-id>D010080</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes>
    <atc-code code="J05AX06">
      <level code="J05AX">Other antivirals</level>
      <level code="J05A">DIRECT ACTING ANTIVIRALS</level>
      <level code="J05">ANTIVIRALS FOR SYSTEMIC USE</level>
      <level code="J">ANTIINFECTIVES FOR SYSTEMIC USE</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1c8m</pdb-entry>
    <pdb-entry>1na1</pdb-entry>
    <pdb-entry>1ncq</pdb-entry>
    <pdb-entry>1ncr</pdb-entry>
    <pdb-entry>1nd3</pdb-entry>
    <pdb-entry>4wm7</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB10317</drugbank-id>
      <name>Rubella virus vaccine</name>
      <description>The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10343</drugbank-id>
      <name>Bacillus calmette-guerin substrain tice live antigen</name>
      <description>The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10804</drugbank-id>
      <name>Bacillus calmette-guerin substrain connaught live antigen</name>
      <description>The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10805</drugbank-id>
      <name>Yellow Fever Vaccine</name>
      <description>The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11003</drugbank-id>
      <name>Anthrax vaccine</name>
      <description>The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11050</drugbank-id>
      <name>Typhoid Vaccine Live</name>
      <description>The therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12386</drugbank-id>
      <name>Bacillus calmette-guerin substrain danish 1331 live antigen</name>
      <description>The therapeutic efficacy of Bacillus calmette-guerin substrain danish 1331 live antigen can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12768</drugbank-id>
      <name>BCG vaccine</name>
      <description>The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14409</drugbank-id>
      <name>Human adenovirus e serotype 4 strain cl-68578 antigen</name>
      <description>The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14443</drugbank-id>
      <name>Vibrio cholerae CVD 103-HgR strain live antigen</name>
      <description>The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14685</drugbank-id>
      <name>Adenovirus type 7 vaccine live</name>
      <description>The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB10318</drugbank-id>
      <name>Varicella Zoster Vaccine (Live/attenuated)</name>
      <description>The therapeutic efficacy of Varicella Zoster Vaccine (Live/attenuated) can be decreased when used in combination with Pleconaril.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>4.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-4.2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.19e-02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>5.04</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>3-{3,5-dimethyl-4-[3-(3-methyl-1,2-oxazol-5-yl)propoxy]phenyl}-5-(trifluoromethyl)-1,2,4-oxadiazole</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>pleconaril</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>381.349</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>381.130026072</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C2=NOC(=N2)C(F)(F)F)=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C18H18F3N3O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KQOXLKOJHVFTRN-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>74.18</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>104.12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>37.46</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>1.64</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>1684</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>175426946</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>1621</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50111469</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>W11</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Pleconaril</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL29609</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0003373</id>
      <name>Polyprotein</name>
      <organism>Enterovirus J</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8V397" source="TrEMBL">
        <name>Genome polyprotein</name>
        <general-function>Structural molecule activity</general-function>
        <specific-function/>
        <gene-name/>
        <locus/>
        <cellular-location>Host cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>7.92</theoretical-pi>
        <molecular-weight>241285.765</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1330521">Enterovirus J</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF414373</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q8V397</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>Q8V397_9ENTO</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms/>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0020668|Genome polyprotein
MGAQVSTQKSGSHETGTYATGGSTINYTNINYYKDSYAASASRQDFSQDPSKFTKPVVDA
LTEAAVPLKSPSAEACGYSDRVLQLTLGNSTITTQEAANIVVGYGKWPEHLKPIDANSID
APTKPDVAVNRFYTLKAKKWEKASKGWMWKLPDCLNDTGIFGQNCWYHFLYRGGWAIHVQ
CNASKFHQGTLLVFLAPDFTRGAPVTGSGTTPNVSYSHAMPGEDGSEFIDPLFLDNGTML
QQATVFPHQWINLRTNNSATIIVPYINNIPADSPVRHNNWTLCVIPVVPLDYSEGATTVV
PITVTLAPMCCEFDGLRNAVPQGLPVKATPGSYQFLTTSDDCSEGLLPNFHSTPEIFIPG
QVNNLLELVQIETMMTVNNTATQASGVGRITIPVSVQSDVDTQIAGFTINPGSDGVFQST
YLGQICRYFNNWSGSIEITFMFCGSFMATGKILIAYTPPGGSAPTDRKSAMLGTHVIWDF
GLQSSATLLIPWISNTCMRNVASLAYQDTYFAGGYVTLWYQTNFVVPSGAPTSARIIALC
AAKGDFCLRLLKDSTDISQSAVLQNSPEQAIEGVISTTIQNLTPQNISASEGSIGAAAPA
LQAAETGATSTATPEGMIETRSVINRQHIAESSVESFYSRAGLVGMVKLEGLQSSTFTTW
TIDTMGFVQQRRKLELFTYMRFDAEFTMLVCAAEEINPYNIQYMYVPPGSGIPTDHDSYL
WQSGTNPSIYVKSTDPPAQFSIPFMSTCAAYAWFYDGYPRSYGPDAEALNKSYGILPANQ
FGTFCMRLLGSALKTTLTVRIYMRPKHIKCWAPRPFRMLPYVEKNRPSYKSPPTDPIKNR
TSITTTGAFGQQSGAVFVGNYKITNLHLASTFDRESEVWSSYERDLIVSSTTAHGCDKLA
RCTCNTGVYFCKSANKHFPVCFQGPGLTFIEANEYYPARYQSHVLLAVGHAQPGDCGGIL
RCEHGVVGILTAGGNGLVAFADLRDLLWIEDDAMEQGVSDYVQRLGSAFGAGFTNEIAEK
TQQIKEMLIGQDSVLEKCLKALIKIVSAMVILIRNHEDLITVTATLALIGCSASPWQWLK
SKVCSYFQVPMAQKQADGWLKKFTEATNAAKGLEWLANKISKFIDWVKSKIVPQVKEKLD
FLSKLKQLPLLESQIATIEHSAPSQEAQETLYGNVQYLAHYCRKFAPLYAAEAKRVYHLE
KRMNNYMQFKTKSRIEPVCLLIHGSPGAGKSVVSSLVGRAIAEKMNSSVYSLPPDPDHFD
GYKQQAVVIMDDLCQNPDGKDVSLLCQMVSTVDFIPPMASLEEKGILYTSPFMIASTNHG
SISAPTISDSRALARRFFLDVDILIHDDYKTETGRLNMPAACMHCTSCDPANFKRCCPII
CGKALMFSDRRTSVRYTTDMLVSEMFREYSHRNSIGNVLEALFQGPPVHKDLKISVAEEV
PPPPAIADLLKSVDSEEVRNYCESKGWIVPAMEINVERHINRAMTILQAVSTFVAVAGCV
FVVYKLFAGFQGAYTGLPFTKPKVPTIRQAKVQGPNFEFAVAMMKRNSCIAKTGQGEFTM
LGIWDKWAVLPRHAKPGDNIIIDDVEVPVEDAKELIDSEGVNLELTLIKLRRNEKFRDIR
GFIPSEAGEINEAVLAINTSKFPNMFIPVGKVHEYGFLNLSGTPTHRMLMYNFPTKSGQC
GGILMATGKVLGIHVGGNGHQGFAATLLRSYFSEEQGEIEWMETNKESGYPIINAPTKTK
LEPSVFHDVFEGKKEPAVLNPRDPRLRVDFEEAIFSKYVGNVNTHVDEYMHEAIDHYAGQ
LMTLDISTEPLCLEDAVYGTEGLEALDLTTSAGYPYVTLGIKKRDILSKKTRDLTKLREC
MDKYGLNLPMVTHVKDELRSVEKVQAGKSRLIEASSLNDSVAMRQTFGNLYRTFHQNPGV
MTGSAVGCNPDTFWSKIPVMLDGELFAFDYTGYDASLSPVWFAALKILLEKIGYTNNETK
YIDYLCNSYHLYKNKHYFVRGGMPSGCSGTSIFNSMINNIIIRTLLLKTYKNIDLDKFRM
IAYGDDVIASYPYAIDAGLLAKAGKEYGLTMTPADKSATFNNVTWENVTFLKRFFRADEQ
FNFLVHPVMPMKEIHESIRWTKDAKNTQEHVRSLCELAWHNGEEAYNEFLSKIRSVPVGR
CLLLPAYSTLRRKWLDSF</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020669|Genome polyprotein
ATGGGTGCACAAGTATCCACACAAAAATCCGGATCTCATGAAACTGGCACTTATGCCACA
GGTGGATCAACAATTAATTACACAAATATAAACTATTACAAAGATAGTTATGCAGCTAGT
GCCTCACGGCAAGATTTTTCACAAGATCCCTCAAAATTCACAAAGCCCGTAGTAGATGCT
CTCACCGAAGCTGCTGTTCCTTTGAAATCACCATCAGCAGAAGCTTGCGGTTATAGTGAC
CGCGTGTTACAATTGACACTAGGCAATTCTACTATTACCACACAGGAAGCTGCTAACATT
GTGGTGGGTTATGGTAAATGGCCAGAACATCTGAAGCCAATTGATGCTAACTCAATAGAT
GCCCCAACAAAACCAGATGTAGCTGTGAACAGGTTTTACACTCTGAAAGCCAAAAAGTGG
GAAAAGGCTTCCAAAGGTTGGATGTGGAAGTTGCCCGATTGTTTGAATGATACCGGAATA
TTTGGCCAAAATTGCTGGTATCATTTCTTATACAGAGGTGGTTGGGCTATACATGTGCAG
TGCAATGCTAGCAAGTTTCACCAGGGTACTCTATTAGTGTTTTTAGCACCAGATTTCACC
AGGGGAGCTCCGGTTACAGGCAGTGGGACTACGCCTAATGTATCTTATTCACATGCCATG
CCTGGAGAAGATGGCTCTGAATTCATAGACCCGCTGTTCTTGGACAACGGTACGATGTTG
CAACAGGCAACTGTTTTCCCCCACCAGTGGATAAATTTGAGAACTAACAACAGCGCAACC
ATTATAGTTCCATATATCAACAACATACCAGCAGACTCCCCTGTTCGACATAATAATTGG
ACTTTGTGTGTGATCCCAGTTGTGCCCTTGGACTACTCAGAGGGGGCTACCACTGTCGTG
CCAATTACAGTGACCCTGGCTCCTATGTGTTGTGAATTTGATGGGTTGAGAAATGCAGTT
CCCCAGGGTTTACCAGTCAAAGCAACTCCAGGTTCGTACCAGTTTTTAACTACCTCTGAT
GACTGTTCTGAAGGTTTGTTACCAAATTTTCATTCTACTCCCGAAATTTTCATCCCTGGT
CAAGTGAATAATTTACTCGAATTAGTGCAAATTGAGACAATGATGACAGTCAATAATACA
GCAACCCAGGCTTCAGGAGTGGGTAGAATCACGATTCCTGTTTCAGTGCAAAGTGATGTG
GACACTCAAATTGCAGGTTTCACAATTAATCCTGGTAGTGATGGAGTGTTTCAGTCAACA
TACCTTGGGCAAATTTGCAGATACTTCAACAACTGGTCAGGGAGCATTGAAATCACTTTC
ATGTTCTGTGGATCCTTCATGGCAACAGGCAAGATCTTAATTGCTTACACACCACCAGGA
GGTAGTGCCCCGACTGATCGCAAAAGTGCAATGTTAGGTACACATGTCATTTGGGATTTT
GGTCTTCAATCCTCAGCCACCCTTCTAATCCCATGGATAAGCAATACGTGTATGAGAAAT
GTTGCCAGTCTAGCTTACCAGGATACCTACTTCGCAGGGGGTTATGTCACTCTGTGGTAC
CAGACAAATTTTGTGGTTCCGTCTGGAGCACCTACATCAGCTAGAATAATTGCCCTTTGT
GCAGCCAAGGGTGATTTTTGTTTGAGATTGCTTAAAGATTCCACAGACATATCACAATCA
GCGGTTTTGCAAAATTCCCCAGAACAAGCCATTGAAGGTGTGATAAGTACGACCATACAG
AACTTGACACCACAGAATATTAGTGCATCTGAAGGATCTATAGGTGCTGCAGCTCCAGCA
CTCCAGGCAGCTGAAACGGGAGCGACCAGCACAGCAACCCCAGAAGGAATGATTGAAACC
AGGAGTGTAATCAATAGACAACACATTGCCGAATCATCTGTAGAATCATTTTACAGCAGA
GCTGGCCTAGTTGGAATGGTGAAACTAGAAGGATTACAATCATCAACATTTACCACGTGG
ACTATTGACACAATGGGTTTTGTCCAACAAAGGCGCAAGCTGGAGTTGTTTACTTACATG
AGATTTGATGCAGAGTTTACCATGCTTGTCTGTGCTGCAGAGGAGATTAATCCTTACAAT
ATTCAGTATATGTACGTTCCACCAGGTAGTGGCATCCCGACTGATCATGACTCATACTTG
TGGCAATCAGGTACCAATCCCTCCATATATGTGAAATCCACAGATCCTCCTGCACAATTT
TCAATCCCCTTTATGTCCACATGTGCAGCTTATGCTTGGTTTTACGATGGTTATCCAAGA
TCATATGGACCAGATGCCGAAGCATTAAATAAATCATATGGCATATTACCAGCAAATCAA
TTTGGCACCTTTTGCATGAGATTACTTGGTAGTGCTCTGAAGACTACATTGACAGTTAGA
ATCTACATGAGGCCAAAGCATATCAAATGTTGGGCACCCAGACCATTTAGGATGTTGCCA
TATGTTGAAAAGAATAGACCATCCTACAAATCACCCCCTACAGATCCAATCAAGAATCGG
ACTAGTATCACCACAACGGGAGCATTTGGACAACAAAGTGGAGCTGTCTTTGTGGGGAAT
TATAAAATTACTAATCTACATCTAGCATCAACCTTTGATCGTGAAAGTGAGGTGTGGTCA
AGTTATGAAAGAGACTTGATTGTGTCGTCCACAACAGCACATGGGTGTGACAAACTAGCT
AGGTGCACCTGCAACACTGGTGTTTACTTTTGTAAATCAGCTAACAAACACTTCCCAGTG
TGTTTCCAGGGTCCGGGTCTCACATTTATTGAGGCCAATGAGTACTACCCAGCGCGATAT
CAGTCCCACGTGCTTCTAGCCGTTGGCCATGCGCAACCAGGCGATTGTGGTGGCATTTTA
CGATGTGAACATGGAGTGGTGGGAATCCTAACAGCAGGTGGGAACGGGTTAGTAGCATTT
GCTGATTTGAGAGACTTGTTGTGGATTGAGGATGATGCCATGGAGCAGGGCGTCTCTGAC
TACGTCCAAAGACTGGGCTCTGCATTTGGTGCCGGGTTCACCAATGAAATTGCAGAAAAA
ACCCAGCAAATCAAGGAGATGCTTATTGGACAAGACTCAGTGTTAGAAAAATGTTTAAAA
GCATTAATCAAAATTGTTTCTGCTATGGTTATACTCATCAGAAATCATGAAGATTTGATA
ACTGTCACTGCCACCCTTGCATTGATTGGATGTAGTGCTAGTCCATGGCAATGGTTGAAA
TCAAAGGTTTGCTCTTATTTCCAAGTACCTATGGCGCAAAAGCAAGCTGATGGATGGTTG
AAGAAGTTCACAGAGGCAACTAATGCTGCCAAAGGGCTTGAGTGGTTGGCAAATAAAATT
AGCAAATTCATCGATTGGGTGAAGTCAAAAATTGTCCCGCAAGTCAAGGAAAAATTAGAT
TTTCTCTCCAAACTGAAACAGTTGCCTCTCTTGGAGAGCCAGATTGCAACCATTGAACAT
AGTGCTCCTAGTCAAGAGGCTCAAGAAACATTATACGGAAATGTGCAGTACTTAGCTCAT
TATTGTAGGAAGTTTGCACCTTTGTATGCCGCTGAAGCCAAGAGAGTATACCACTTAGAA
AAGAGAATGAACAATTACATGCAGTTCAAGACCAAATCCCGCATTGAACCTGTATGTTTA
TTGATTCACGGGAGTCCTGGTGCAGGGAAATCAGTTGTTTCTAGTTTAGTTGGGCGTGCA
ATTGCAGAGAAAATGAACAGTTCAGTGTACTCACTCCCACCAGACCCAGACCATTTTGAT
GGGTATAAACAACAAGCTGTAGTTATCATGGATGATTTATGTCAAAACCCAGATGGTAAA
GATGTTTCACTACTCTGCCAAATGGTGTCAACAGTTGATTTCATACCTCCAATGGCATCT
TTGGAAGAAAAAGGCATACTATATACTTCACCATTTATGATTGCCTCAACAAATCATGGA
AGCATCAGTGCACCCACCATTTCGGATAGTAGAGCTTTGGCTCGTAGATTTTTCCTTGAT
GTTGACATCCTTATTCACGATGATTACAAGACTGAAACAGGGAGACTGAACATGCCAGCT
GCATGTATGCATTGCACCTCATGTGATCCAGCAAACTTCAAAAGGTGCTGCCCTATAATC
TGTGGTAAAGCTTTAATGTTCAGTGATAGACGAACATCTGTAAGATACACTACGGACATG
CTAGTTTCAGAGATGTTCAGGGAATATTCACACAGAAATTCAATTGGCAACGTACTAGAA
GCACTTTTCCAAGGTCCACCAGTGCACAAGGACTTGAAAATCTCAGTTGCAGAAGAAGTA
CCACCACCACCAGCCATTGCAGACCTTTTAAAGTCAGTGGACTCAGAGGAGGTCAGAAAC
TATTGTGAATCAAAAGGATGGATAGTACCTGCCATGGAAATTAATGTTGAGAGACACATC
AATAGAGCAATGACTATTCTCCAAGCTGTGTCCACCTTTGTTGCTGTTGCAGGGTGTGTG
TTTGTAGTTTACAAACTATTTGCTGGATTCCAAGGAGCCTATACTGGTCTCCCTTTCACC
AAACCTAAAGTTCCAACCATCAGACAAGCAAAAGTGCAAGGTCCAAATTTTGAGTTTGCT
GTTGCAATGATGAAAAGAAACTCGTGTATTGCAAAGACAGGTCAAGGAGAGTTCACTATG
CTTGGAATCTGGGACAAGTGGGCGGTCCTTCCGCGTCACGCTAAGCCAGGAGATAATATA
ATTATCGATGATGTGGAGGTCCCAGTGGAAGATGCAAAGGAACTCATTGACTCAGAGGGG
GTAAATCTAGAGTTGACACTGATCAAACTCAGGAGAAATGAGAAGTTTAGAGACATCAGA
GGGTTCATCCCATCAGAGGCGGGGGAGATCAATGAAGCTGTTTTGGCTATCAATACTAGC
AAGTTCCCAAACATGTTCATCCCAGTTGGAAAAGTACACGAATATGGGTTTCTCAATTTG
AGTGGCACTCCCACCCACAGGATGTTAATGTACAACTTCCCAACCAAATCAGGACAATGC
GGAGGCATACTCATGGCTACAGGTAAGGTGTTAGGAATCCATGTTGGTGGCAATGGGCAC
CAGGGCTTTGCTGCAACTCTTTTGAGATCATATTTCAGTGAAGAGCAAGGTGAGATTGAA
TGGATGGAGACCAACAAGGAGTCAGGTTATCCCATAATCAATGCACCAACCAAGACAAAA
CTAGAACCCAGCGTCTTTCATGATGTTTTTGAGGGAAAGAAGGAGCCTGCTGTGTTGAAC
CCCCGTGATCCCAGGTTGAGAGTTGATTTTGAAGAAGCTATCTTCTCCAAATATGTGGGT
AATGTTAACACACATGTGGATGAATACATGCATGAAGCAATTGATCACTATGCAGGTCAA
CTCATGACATTGGATATTAGCACTGAACCTCTTTGTCTGGAAGATGCTGTGTATGGAACT
GAAGGATTGGAAGCACTAGATCTAACAACTAGTGCAGGTTATCCTTATGTGACACTGGGT
ATAAAGAAGAGGGACATTCTTTCCAAAAAGACCAGAGACCTTACCAAATTAAGGGAATGC
ATGGATAAGTATGGACTCAACTTACCAATGGTCACCCATGTCAAAGATGAGCTGAGAAGT
GTGGAGAAAGTGCAAGCTGGTAAATCCCGCTTGATTGAAGCTTCCAGTTTGAATGATTCA
GTAGCCATGAGACAGACATTTGGAAACCTGTACAGAACCTTCCACCAAAATCCAGGCGTC
ATGACAGGTAGTGCAGTGGGATGCAACCCTGATACCTTCTGGAGCAAGATACCAGTGATG
TTAGATGGTGAACTTTTCGCCTTTGACTACACAGGGTATGACGCTTCCCTCAGCCCGGTC
TGGTTCGCAGCTCTAAAAATATTGCTGGAGAAAATTGGATACACCAACAATGAGACCAAG
TACATTGATTATTTGTGTAACTCCTATCACCTTTACAAAAATAAACATTATTTTGTTAGA
GGGGGCATGCCATCTGGTTGCTCAGGGACTTCCATCTTCAACAGTATGATCAACAACATT
ATAATAAGGACTTTACTCTTGAAGACATACAAGAACATTGACTTGGATAAATTCAGGATG
ATAGCATACGGTGATGATGTCATTGCAAGTTACCCGTATGCTATTGATGCAGGCCTACTT
GCTAAGGCGGGAAAGGAGTATGGCCTGACGATGACACCAGCAGATAAGTCTGCCACCTTC
AACAATGTGACGTGGGAAAACGTCACCTTCTTGAAGAGATTCTTCAGGGCTGACGAACAA
TTCAATTTTTTGGTTCATCCTGTCATGCCTATGAAGGAAATTCATGAGTCAATCAGATGG
ACTAAAGATGCTAAGAACACTCAAGAACATGTGAGATCGTTATGCGAATTGGCATGGCAT
AACGGTGAAGAGGCTTACAATGAATTTTTATCAAAAATAAGGAGTGTTCCAGTGGGTCGA
TGCCTTTTGCTTCCGGCTTATTCGACACTTAGACGGAAATGGCTTGACTCTTTCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00680</identifier>
            <name>RdRP_1</name>
          </pfam>
          <pfam>
            <identifier>PF08727</identifier>
            <name>P3A</name>
          </pfam>
          <pfam>
            <identifier>PF00548</identifier>
            <name>Peptidase_C3</name>
          </pfam>
          <pfam>
            <identifier>PF02226</identifier>
            <name>Pico_P1A</name>
          </pfam>
          <pfam>
            <identifier>PF00947</identifier>
            <name>Pico_P2A</name>
          </pfam>
          <pfam>
            <identifier>PF01552</identifier>
            <name>Pico_P2B</name>
          </pfam>
          <pfam>
            <identifier>PF00073</identifier>
            <name>Rhv</name>
          </pfam>
          <pfam>
            <identifier>PF00910</identifier>
            <name>RNA_helicase</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>host cell cytoplasmic vesicle</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral to membrane of host cell</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>viral capsid</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>cysteine-type endopeptidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ion channel activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA helicase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA-directed RNA polymerase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>structural molecule activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>pore formation by virus in membrane of host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein oligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>RNA-protein covalent cross-linking</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral entry into host cell</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>viral RNA genome replication</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>virion attachment to host cell</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>